International audienceCarcinosarcomas are rare uterine cancers and carry poor prognosis. Although these tumours usually arise de novo, some cases developed under tamoxifen therapy have been reported. We report two more cases of uterine carcinosarcoma occurring in two postmenopausal patients benefiting from tamoxifen therapy as adjuvant treatment of breast cancer. A review of the literature is undertaken
AimReport the outcome of 8 patients (pts) with breast cancer (BC) treated with Tamoxifen (TAM) that ...
© 2016, University of Kragujevac, Faculty of Science, All rights reserved. The term ‘mixed Müllerian...
Tamoxifen is the drug of choice in the treatment of breast cancer. Recent reports show an increased ...
BACKGROUND AND OBJECTIVE: Uterine carcinosarcoma, also known as malignant mixed Mullerian...
Background: Uterine malignant mixed müllerian tumor, also known as carcinosarcoma, is a biphasic tu...
Uterine carcinosarcoma is a rare aggressive tumor also known as Malignant Mixed Mullerian Tumor. Pr...
Carcinosarcome utérin associé au traitement par le Tamoxifène et révélé par des algies pelviennes ch...
Uterine carcinosarcoma, which is categorized as high-grade endometrial cancer, is an uncommon kind o...
WOS: 000233289200049PubMed ID: 16343223Tamoxifen (TAM) is widely used in the treatment of breast can...
A 71-year-old patient developed an uterine adenosarcoma two months after two years of tamoxifen adju...
It is well known that a large number of patients treated with Tamoxifen develops endometrial patholo...
Carcinosarcoma of the uterus is a rare tumor representing 2-4 % of uterine malignancies. Its prognos...
Carcinosarcoma is a rare tumor of the uterus with a poor prognosis. We present a case of uterine car...
Uterine carcinosarcomas are rare and extremely aggressive undifferentiated carcinomas which include ...
Uterine carcinosarcoma is a highly aggressive neoplasm with tendency to early recurrence and/or meta...
AimReport the outcome of 8 patients (pts) with breast cancer (BC) treated with Tamoxifen (TAM) that ...
© 2016, University of Kragujevac, Faculty of Science, All rights reserved. The term ‘mixed Müllerian...
Tamoxifen is the drug of choice in the treatment of breast cancer. Recent reports show an increased ...
BACKGROUND AND OBJECTIVE: Uterine carcinosarcoma, also known as malignant mixed Mullerian...
Background: Uterine malignant mixed müllerian tumor, also known as carcinosarcoma, is a biphasic tu...
Uterine carcinosarcoma is a rare aggressive tumor also known as Malignant Mixed Mullerian Tumor. Pr...
Carcinosarcome utérin associé au traitement par le Tamoxifène et révélé par des algies pelviennes ch...
Uterine carcinosarcoma, which is categorized as high-grade endometrial cancer, is an uncommon kind o...
WOS: 000233289200049PubMed ID: 16343223Tamoxifen (TAM) is widely used in the treatment of breast can...
A 71-year-old patient developed an uterine adenosarcoma two months after two years of tamoxifen adju...
It is well known that a large number of patients treated with Tamoxifen develops endometrial patholo...
Carcinosarcoma of the uterus is a rare tumor representing 2-4 % of uterine malignancies. Its prognos...
Carcinosarcoma is a rare tumor of the uterus with a poor prognosis. We present a case of uterine car...
Uterine carcinosarcomas are rare and extremely aggressive undifferentiated carcinomas which include ...
Uterine carcinosarcoma is a highly aggressive neoplasm with tendency to early recurrence and/or meta...
AimReport the outcome of 8 patients (pts) with breast cancer (BC) treated with Tamoxifen (TAM) that ...
© 2016, University of Kragujevac, Faculty of Science, All rights reserved. The term ‘mixed Müllerian...
Tamoxifen is the drug of choice in the treatment of breast cancer. Recent reports show an increased ...